The Czech Republic has reached an important milestone in the implementation of its nationwide Prostate Cancer Screening Pilot Programme, with the first results now published in the international journal European Urology Open Science.
The publication, titled Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Programme, represents an important recognition of the Czech experience and its contribution to the development of organised prostate cancer screening in Europe.
Launched in January 2024, the programme targets men aged 50-69 years and aims to facilitate early detection of prostate cancer through a structured screening pathway based on PSA testing and subsequent risk-adapted diagnostic assessment.
The first-year results demonstrate the feasibility of implementing a nationwide screening programme within the Czech healthcare system. More than 150,000 men were offered screening, with PSA results available for over 146,000 participants. In 8.8% of those tested, heightened PSA levels were found. The results also highlight the increasing use of prostate MRI prior to biopsy, reflecting the integration of European recommendation into routine clinical practice.
Publication provides real-world evidence that may contribute to the future development of organized prostate cancer screening strategies across Europe. You can read the full article here.
Marcela Koudelková
Kateřina Hejcmanová
Marek Babjuk
Jiří Ferda
Ola Bratt
Renata Chloupková
Ondřej Ngo
Karel Hejduk
Vlastimil Válek
Ondřej Májek
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor HaDEA can be held responsible for them.
This website is managed by 6th DYPEDE, Greece.